Methodology Issues in a Tailored Light Treatment for Persons With Dementia

  • STATUS
    Recruiting
  • End date
    Dec 31, 2025
  • participants needed
    45
  • sponsor
    Icahn School of Medicine at Mount Sinai
Updated on 1 April 2022
depression
depressed mood
mini-mental state examination
alzheimer's disease
mental state examination
agitation
Accepts healthy volunteers

Summary

Tailored light treatment will increase sleep efficiency, reduce depression and reduce agitation scores in those with Alzheimer's disease and related dementia

Description

In a within subjects, randomized placebo control study, a tailored light treatment will be used for short-term (4 weeks). Outcome measures include sleep measures (actigraphy), and questionnaires probing behavior and mood in those who have been diagnosed with Alzheimer's disease and related dementia. After a 4-week washout period, a placebo control inactive light will be used for another 4 weeks.

Details
Condition Dementia,Sleep Disturbances, Depression
Treatment Tailored Active intervention, Inactive intervention
Clinical Study IdentifierNCT01816152
SponsorIcahn School of Medicine at Mount Sinai
Last Modified on1 April 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

mild to moderate Alzheimer's disease and related dementia (ADRD) based on National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria
Clinical Dementia Rating (CDR) of 1 to 2
Mini-Mental State Examination (MMSE) between 8 and 24

Exclusion Criteria

major organ failure
major illness
history of head injury
hypertension or diabetes
use psychotropic (sleep aid) medicine, obstructing cataracts, macular degeneration, and blindness
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note